A phase I study of oral UFT/leucovorin and irinotecan, plus radiation for locally recurrent rectal cancer

Objectives: The aim of this phase I study is to identify the maximum tolerated dose (MTD) and recommended dose (RD) of CPT-11 in combination with UFT/LV and radiation in patients with locally recurrent rectal cancer. Methods: Patients with histologically proven rectal cancer with local recurrence we...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Masataka, Sekimoto, Mitsugu, Fukunaga, Yosuke, Konishi, Koji, Fujiwara, Yushi, Mizushima, Tsunekazu, Takemasa, Ichiro, Yamamoto, Hirofumi, Doki, Yuichiro, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Society of Coloproctology 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768668/
https://www.ncbi.nlm.nih.gov/pubmed/31583301
http://dx.doi.org/10.23922/jarc.2016-009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768668/
https://www.ncbi.nlm.nih.gov/pubmed/31583301
http://dx.doi.org/10.23922/jarc.2016-009

Ejemplares similares